Characteristics of the 206 patients enrolled in the cohort study
| HCV 1b | HCV 2c | |
|---|---|---|
| *Median (range). | ||
| ALT, alanine aminotransferase; HCV, hepatitis C virus. | ||
| No of patients (males) | 106 (60) | 100 (60) |
| Mean (SD) age (y) | 48 (10) | 49 (9) |
| Mean (SD) disease duration (months) | 91 (85) | 94 (100) |
| Modality of infection | 24 (23%) | 24 (24%) |
| Transfusion | 23 (22%) | 23 (23%) |
| Occupational/sex | 1 (1%) | 1 (1%) |
| Unknown | 82 (77%) | 76 (76%) |
| ALT (IU/l)* | 114 (18–308) | 137 (10–514) |
| Anti-HBc | ||
| Negative | 88 (83%) | 82 (82%) |
| Positive | 18 (17%) | 18 (18%) |
| Bilirubin (mg/dl) | 0.7 (0.4–13) | 0.7 (0.6–14) |
| Histological grading | ||
| 3–7 | 58 (55%) | 45 (45%) |
| 8–10 | 35 (33%) | 28 (28%) |
| 11–15 | 9 (8%) | 12 (12%) |
| Histological staging | ||
| 0–2 | 54 (51%) | 46 (46%) |
| 3/4 | 20 (19%) | 17 (17%) |
| 5/6 | 28 (26%) | 22 (22%) |